(RTTNews) - Drugmaker Pfizer Inc. (PFE) said Friday that the U.S. Patent and Trademark Office or USPTO recently issued a U.S. Patent Term Extension (PTE) certificate for IBRANCE, or palbociclib. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback